Biogen Inc. buy Royal Bank of Canada
Start price
13.02.25
/
50%
€130.50
Target price
13.02.26
€215.73
Performance (%)
-10.00%
Price
25.08.25
€117.45
Summary
This prediction is currently active. With a performance of -10.00%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 13.02.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 0.295% | 0.295% |
| iShares Core DAX® | -0.099% | 0.273% |
| iShares Nasdaq 100 | -1.085% | 1.502% |
| iShares Nikkei 225® | -0.835% | 3.273% |
| iShares S&P 500 | 0.099% | 1.988% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $231.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat